CJC1295/DAC 5mg

PEPTIDE CLASS

Growth Hormone-Releasing Hormone (GHRH) Analog • Long-Acting Growth Hormone Secretagogue

OVERVIEW

CJC-1295 with Drug Affinity Complex (DAC) is a long-acting synthetic analog of Growth Hormone-Releasing Hormone (GHRH). The addition of the Drug Affinity Complex extends the peptide's circulating half-life by allowing reversible binding to serum albumin, providing sustained activation of GHRH receptors over an extended period.

CJC-1295 with DAC is widely researched for its ability to stimulate the natural pulsatile release of growth hormone (GH) and increase circulating insulin-like growth factor-1 (IGF-1) levels through activation of the pituitary gland. Due to its prolonged duration of action, it has become an important investigational compound in studies examining endocrine physiology, metabolism, body composition, recovery, and healthy aging.

Research continues to explore the long-term effects of sustained GHRH receptor activation and its influence on multiple physiological systems.

POTENTIAL RESEARCH BENEFITS

Current research is exploring CJC-1295 with DAC for its potential to:

• Investigate endogenous growth hormone secretion

• Study insulin-like growth factor-1 (IGF-1) regulation

• Explore body composition and lean tissue physiology

• Support recovery and tissue remodeling research

• Investigate protein synthesis pathways

• Study metabolic regulation and energy utilization

• Examine healthy aging and endocrine function

• Explore sleep-related growth hormone physiology

  
  

  MECHANISM OF ACTION

CJC-1295 with DAC functions by binding to Growth Hormone-Releasing Hormone (GHRH) receptors located in the anterior pituitary gland. This stimulates the physiological release of endogenous growth hormone, which subsequently promotes hepatic production of IGF-1.

The Drug Affinity Complex (DAC) prolongs peptide activity by reversibly binding to circulating albumin, significantly extending its half-life compared to native GHRH. This sustained receptor activation allows researchers to investigate prolonged growth hormone signaling while maintaining the body's natural endocrine feedback mechanisms

PRODUCT SPECIFICATIONS

Compound Name: CJC-1295 with DAC

Peptide Type: Long-Acting Synthetic GHRH Analog

Research Category: Growth Hormone Secretagogue

Peptide Length: 30 Amino Acids

Molecular Weight: Approximately 3,364 Da

Appearance: White to off-white lyophilized powder

What is CJC-1295 with DAC?

CJC-1295 with DAC is a modified Growth Hormone-Releasing Hormone analog designed to provide prolonged stimulation of endogenous growth hormone secretion. Its extended half-life has made it a widely studied compound in research involving endocrine regulation, metabolism, recovery, and growth hormone physiology.

What is CJC-1295 with DAC commonly researched for?

Researchers commonly investigate CJC-1295 with DAC in studies involving:

• Growth hormone secretion

• IGF-1 production

• Endocrine physiology

• Body composition

• Protein synthesis

• Tissue repair and recovery

• Metabolic function

• Healthy aging

• Sleep physiology

• Exercise recovery